Related Experiment Video
Updated: May 1, 2026

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis
Published on: June 8, 2020
mTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigation
Zhi Tang1, Ahmet Tarik Baykal, Hui Gao
1KI-Alzheimer Disease Research Center, Karolinska Institutet , SE 14186 Huddinge, Sweden.
Abstract:
mTor plays a central role in controlling protein homeostasis and cell survival. Recently, we have demonstrated that perturbations of mTor signaling are implicated in Alzheimer's disease (AD) and that mTor complex 1 (mTorC1) is involved in the formation of toxic phospho-tau. Therefore, we employed mass-spectrometry-based proteomics to identify specific protein expression changes in relation with cell survival in human neuroblastoma SH-SY5Y cells expressing genetically modified mTor. Cell death in SH-SY5Y cells was induced by moderate serum deprivation. Using flow cytometry we observed that up-regulated mTor complex 2 (mTorC2) increases the number of viable cells. By using a combination approach of proteomic and enrichment analysis we have identified several proteins (Thioredoxin-dependent peroxide reductase, Peroxiredoxin-5, Cofilin 1 (non-muscle), Annexin A5, Mortalin, and 14-3-3 protein zeta/delta) involved in mitochondrial integrity, apoptotosis, and pro-survival functions (caspase inhibitor activity and anti-apoptosis) that were significantly altered by mTor activity modulation. The major findings of this study are the implication of mTorC2 but not mTorC1 in cell viability modulation by activating the pro-survival machinery. Taken together, these results suggest that up-regulated mTorC2 might be playing an important role in promoting cell survival by suppressing the mitochondria-caspase-apoptotic pathway in vitro.
Insights
Mammalian target of rapamycin complex 2 (mTORC2) promotes cell survival by activating pro-survival proteins and inhibiting the mitochondria-caspase-apoptotic pathway. This mTORC2 activity was observed in neuroblastoma cells under serum deprivation.
Area of Science:
- Cell Biology
- Neuroscience
- Molecular Biology
Background:
- Mammalian target of rapamycin (mTOR) is crucial for protein homeostasis and cell survival.
- mTOR signaling pathway dysregulation is linked to Alzheimer's disease (AD).
- mTOR complex 1 (mTORC1) is implicated in the formation of toxic phospho-tau in AD.
Purpose of the Study:
- To investigate the role of mTOR signaling in cell survival using genetically modified human neuroblastoma SH-SY5Y cells.
- To identify specific protein expression changes related to cell survival modulated by mTOR activity.
- To determine the distinct roles of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) in cell viability.
Main Methods:
- Mass-spectrometry-based proteomics to analyze protein expression changes.
- Flow cytometry to assess cell viability.
- Genetic modification of mTOR in SH-SY5Y cells.
- Induction of cell death via moderate serum deprivation.
Main Results:
- Up-regulated mTOR complex 2 (mTORC2) significantly increased the number of viable cells.
- Proteomic analysis identified key proteins involved in mitochondrial integrity, apoptosis, and pro-survival functions altered by mTOR modulation.
- Proteins identified include Thioredoxin-dependent peroxide reductase, Peroxiredoxin-5, Cofilin 1, Annexin A5, Mortalin, and 14-3-3 protein zeta/delta.
Conclusions:
- mTORC2, not mTORC1, plays a significant role in modulating cell viability.
- mTORC2 promotes cell survival by activating pro-survival mechanisms and suppressing the mitochondria-caspase-apoptotic pathway.
- Upregulated mTORC2 may be a key factor in promoting cell survival in vitro.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
MAPK Signaling Cascades
Microtubules in Signaling

